What Does End-of-Life Care Look Like for Stomach Cancer?
By CRYSTAL BAI •
The short answer: End-of-life care for stomach (gastric) cancer focuses on managing severe nausea, inability to eat, pain, and the complications of advanced disease. Gastric cancer has a poor prognosis when diagnosed at advanced stages; most patients in the US are diagnosed at stage III or IV. Hospice is appropriate when systemic therapy is no longer effective and comfort is the priority.
Gastric Cancer Prognosis and Why End-of-Life Planning Matters Early
Stomach (gastric) cancer is one of the most common cancers worldwide, though rates in the US have declined. Early-stage gastric cancer (stages I–II) has reasonable cure rates with surgery. However, most Americans are diagnosed at stage III or IV, where 5-year survival is 20% (stage III) or approximately 5% (stage IV). Systemic therapy (chemotherapy combinations, trastuzumab for HER2-positive disease, immunotherapy) extends survival but is generally not curative for advanced disease.
Because of this prognosis, early advance care planning — before the person is too ill to participate — is critically important.
Symptoms That Dominate the End-of-Life Period
Inability to eat and severe nausea: As gastric cancer advances or recurs after surgery, eating becomes progressively difficult or impossible. Tumor obstruction of the stomach, surgical complications, peritoneal metastases causing bowel dysfunction, and treatment side effects all contribute. Nausea and vomiting can be severe. Anti-emetic medications (ondansetron, metoclopramide, haloperidol in refractory cases, dexamethasone) provide relief. A palliative gastric stent or venting gastrostomy tube may provide comfort in selected patients.
Malnutrition and weight loss: Gastric cancer causes profound cachexia (cancer-related wasting). Families often struggle to watch significant weight loss and want to "feed" the person more. Appetite stimulants (megestrol acetate, dexamethasone) may provide temporary benefit; parenteral nutrition (TPN) is generally not recommended in terminal cancer as it does not extend meaningful life and carries significant complications.
Abdominal pain: From the tumor itself, peritoneal involvement, bowel obstruction, or metastases, abdominal pain in advanced gastric cancer is often severe and complex. A combination of opioids and adjuvant medications (nerve blocks, interventional pain management) provides better relief than opioids alone.
Ascites: Peritoneal metastases from gastric cancer commonly cause malignant ascites — fluid accumulation in the abdomen causing distension, discomfort, and breathlessness. Repeated therapeutic paracentesis (draining fluid) provides relief and can continue in hospice as a comfort measure. An indwelling peritoneal catheter allows home drainage and reduces hospital visits.
Peritoneal carcinomatosis: Spread of gastric cancer to the peritoneal surface (lining of the abdominal cavity) causes diffuse pain, bowel dysfunction, and eventual bowel obstruction. Managing this requires aggressive symptom management including anti-nausea medications, octreotide (to reduce secretions in bowel obstruction), and opioids.
Hospice for Gastric Cancer
Gastric cancer patients typically qualify for hospice when systemic therapy has failed, performance status is significantly impaired, and the patient has chosen comfort-focused care. The complex symptom burden of advanced gastric cancer — particularly nausea, vomiting, and pain — benefits from an experienced hospice palliative care team. Inpatient hospice (GIP level of care) may be needed for severe symptom management.
Frequently Asked Questions
When should a gastric cancer patient enter hospice?
Hospice is appropriate for gastric cancer when systemic therapy is no longer effective, performance status has declined significantly (ECOG 3-4), and the patient has chosen comfort over further disease-directed treatment. Complex symptoms including severe nausea, pain, and malignant ascites benefit from specialized hospice palliative care, including inpatient GIP level of care if needed for symptom management.
What causes severe nausea in advanced stomach cancer?
Nausea in advanced gastric cancer results from gastric outlet obstruction (tumor blocking the stomach's exit), peritoneal metastases disrupting bowel motility, constipation from opioids, malignant ascites, and central nausea from metabolic causes. Multiple anti-emetic agents targeting different pathways (serotonin antagonists, dopamine antagonists, corticosteroids) are often needed simultaneously.
How is malignant ascites managed in stomach cancer hospice?
Malignant ascites (peritoneal fluid) causes abdominal distension, discomfort, and breathlessness. Therapeutic paracentesis (draining fluid via needle) provides significant relief and can be performed as a comfort measure in hospice. An indwelling peritoneal catheter (like the PleurX catheter) can be placed to allow fluid drainage at home, reducing the need for repeated hospital or clinic visits.
Should a stomach cancer patient with advanced disease pursue a feeding tube?
A feeding tube (PEG or J-tube) is generally not recommended in terminal gastric cancer as it does not meaningfully extend life, carries risks including tube-related complications and aspiration, and may worsen nausea and ascites in the context of peritoneal metastases. Comfort-focused oral feeding — offering preferred foods in small amounts, focusing on pleasure rather than nutrition — is the preferred approach in hospice.
What is the most common cause of death in advanced gastric cancer?
Death in advanced gastric cancer typically results from malnutrition and cachexia, progressive bowel obstruction from peritoneal carcinomatosis, sepsis from infection, or multi-organ failure from widespread metastatic disease. The peritoneal and liver metastasis pattern is particularly associated with a short terminal phase.
Renidy connects grieving families with compassionate death doulas and AI-powered funeral planning tools. Try our free AI funeral planner or find a death doula near you.